IIM
RARE icon

INTECH Investment Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

INTECH Investment Management’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$578K Buy
+17,316
New +$430K 0.01% 1290
2025
Q2 		– Sell
-12,839
Closed -$465K – 2628
2025
Q1 		$465K Buy
+12,839
New +$534K ﹤0.01% 1652

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

INTECH Investment Management's RARE Position: Q2 2026 in Review

INTECH Investment Management opened a new position in Ultragenyx Pharmaceutical (RARE) in Q2 2026: 17,316 shares worth $578K. The stake represents 0.01% of the portfolio and ranks #1290 among its holdings. This is a return to the name: INTECH Investment Management previously reported a position in RARE as recently as Q1 2025.

INTECH Investment Management first reported a position in RARE in Q1 2025 and has held it in 2 quarters since. 311 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • INTECH Investment Management held 17,316 shares of Ultragenyx Pharmaceutical worth $578K as of Q2 2026.
  • Ultragenyx Pharmaceutical was a new INTECH Investment Management position in Q2 2026.
  • Ultragenyx Pharmaceutical made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1290 holding.
  • INTECH Investment Management first reported a position in Ultragenyx Pharmaceutical in Q1 2025 and has held it in 2 quarters since.
  • 311 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.